New Orleans, LA - A randomized, controlled trial found that treatment with an implantable cardioverter defibrillator (ICD) on top of standard medications reduced the hazard ratio for five-year ...

WARNING: The Thumbs up, thumbs down commentaries are freewheeling, sometimes contentious, always interesting discussions about the latest clinical trials affecting cardiologists.These discussions may ...

NICM: 6.10 appropriate treatments per 100 patient-years MI/CAD: 8.64 appropriate treatments per 100 patient-years The rate of appropriate LifeVest treatments in SCD-PROTECT was significantly higher ...

81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...